Opinion

Video

Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)

Key Takeaways

  • Oral JAK inhibitors provide a convenient alternative to injectable biologics, potentially enhancing patient adherence in maintenance therapy.
  • These inhibitors target specific inflammatory pathways, offering a tailored approach to managing autoimmune conditions.
SHOW MORE

Medical experts review the data on the use of oral JAK inhibitors for maintenance and rescue treatments in atopic dermatitis.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Aflibercept 8 mg Shows Durability at 3 Years in Wet AMD with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
Investigating Brensocatib, Potential First Treatment for Bronchiectasis, with James Chalmers, MBChB, PhD
Aflibercept 8 mg Noninferior for RVO in QUASAR with W. Lloyd Clark, MD | Image Credit: Palmetto Retinal Center
AI in Dermatology: Emerging Insights and Diverging Perspectives
© 2025 MJH Life Sciences

All rights reserved.